Porsolt - Preclinical CRO

Porsolt is a long-established preclinical CRO, accredited by AAALAC and fully GLP compliant. With our Scientist-to-Scientist approach we support you at every step of the preclinical development process, providing the best scientific advice and offering tailored solutions to meet your needs. We have a recognized international reputation for in vitro, ex vivo, and in vivo expertise in physiopathological models, customized procedures, histology, biomarkers, and tailored solutions for discovering treatments in over 10 different therapeutic areas. We also offer services for safety evaluation of drug candidates from screening to pre-Phase 1 regulatory studies (ICH S7), in full compliance with GLP. Our...

Efficacy & safety pharmacology,cardiovascular system,central nervous system,inflammation,metabolism & eating disorders,gastrointestinal system,abuse and dependence liability,pk & pd,oncology,renal & urogenital systems,pain,dermatology,predictive toxicity,liver & hepatic system,respiratory system,thrombosis & blood,early-drug discovery,screening,efficacy,and safety

Porsolt - preclinical cro operates in the Research industry.

Porsolt - preclinical cro's revenue is 11m - 100m

Porsolt - preclinical cro has 51 - 200 employees.